Avidity Partners Management »

Teva Pharmaceutical Industries shares owned by Avidity Partners Management

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Avidity Partners Management from 13F filings

Historical chart of Avidity Partners Management investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Avidity Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Avidity Partners Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $10M 510k 20.20
2025-06-30 $12M 690k 16.76
2025-03-31 $7.4M 481k 15.37

More positions owned by Avidity Partners Management

Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Medtronic SHS (MDT)
Boston Scientific Corporation (BSX)
Oruka Therapeutics (ORKA)
Bristol Myers Squibb (BMY)
Natera (NTRA)
Danaher Corporation (DHR)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Perspective Therapeutics Com New (CATX)
Jade Biosciences Com New (JBIO)
Pfizer (PFE)
Thermo Fisher Scientific (TMO)
Context Therapeutics (CNTX)
Genmab A/s Sponsored Ads (GMAB)

View all positions for Avidity Partners Management

Top funds holding Teva Pharmaceutical Industries

BlackRock
Phoenix Holdings
Menora Mivtachim Holdings
Harel Insurance Investments & Financial Services
Migdal Insurance & Financial Holdings
Clal Insurance Enterprises Holdings
Exor Investments
Rubric Capital Management
FMR
PointState Capital
State Street Corporation
Glenview Captal Management
Duquesne Family Office
Jane Street
Susquehanna International

View all funds holding Teva Pharmaceutical Industries